Brevetti EPO No.3768241 2021.09.08
Brevetti EPO
(10) Registration Number and Date
2021000638 2021.11.25
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2021/000638 2019.03.18
(40) Publication Number and Date
SM /T/2021/000638 2021.11.25
(30) Priority Details
EP 18162664
2018.03.19
(51) IPC Classes
(71/73) Applicant
(IT) MC2 THERAPEUTICS LIMITED : James House Emlyn Lane, LeatherheadSurrey KT22 7EP, GB
(72) Inventor
(IT) LENON, Stephen : c/o MC2 Therapeutics Limited James House, Emlyn Lane, Leatherhead Surrey KT22 7EP, GB
(IT) PRAESTEGAARD, Morten : c/o MC2 Therapeutics Limited James House, Emlyn Lane, Leatherhead Surrey KT22 7EP, GB
(IT) GEORGIOU, Michelle : c/o MC2 Therapeutics Limited James House, Emlyn Lane, Leatherhead Surrey KT22 7EP, GB
(IT) CRUTCHLEY, Nigel : c/o MC2 Therapeutics Limited James House, Emlyn Lane, Leatherhead Surrey KT22 7EP, GB
(74) Representative Name
(IT) SANTI, Filippo : Via Consiglio dei Sessanta, 99, 47891 Dogana RSM, SM
(54) Title
(IT) COMPOSIZIONE TOPICA COMPRENDENTE CALCIPOTRIOLO E BETAMETASONE DIPROPIONATO
(EN) TOPICAL COMPOSITION COMPRISING CALCIPOTRIOL AND BETAMETHASONE DIPROPIONATE
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2022.01.10
Event NameDateStatus
Filing2019.03.18Filed
Brevetto EPO concesso2021.11.25Published
Ricevuta pagamento annualita 42022.02.28Payed
Ricevuta pagamento annualita 52023.03.31Payed
Ricevuta pagamento annualita 62024.03.27Payed
Ricevuta pagamento annualita 72025.03.28Payed